Blue Owl Capital Holdings’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.9M | Sell |
997,107
-40,000
| -4% | -$640K | 5.15% | 5 |
|
|
2025
Q1 | $15.8M | Sell |
1,037,107
-42,214
| -4% | -$642K | 5.09% | 5 |
|
|
2024
Q4 | $21.9M | Sell |
1,079,321
-451,080
| -29% | -$9.15M | 5.04% | 7 |
|
|
2024
Q3 | $39.3M | Sell |
1,530,401
-185,000
| -11% | -$4.76M | 7.59% | 3 |
|
|
2024
Q2 | $22.1M | Buy |
1,715,401
+268,000
| +19% | +$3.45M | 6.14% | 7 |
|
|
2024
Q1 | $32M | Buy |
1,447,401
+115,099
| +9% | +$2.54M | 6.39% | 5 |
|
|
2023
Q4 | $32.4M | Buy |
+1,332,302
| New | +$32.4M | 7.74% | 4 |
|